ESC 365 - Does first line AF ablation improve outcome in hypertrophic cardiomyopathy patients?

ESC Professional Premium Access

Does first line AF ablation improve outcome in hypertrophic cardiomyopathy patients?

Session: When to consider AF ablation: outcome and survival in specific cohorts

Topic: Treatment

Speaker: Doctor A. Creta (London, GB)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Antonio Creta

Barts Heart Centre, London (United Kingdom of Great Britain & Northern Ireland)

1 presentation

1 follower

4 more presentations in this session

Does first line atrial fibrillation ablation improve survival in HFrEF?

Speaker: Professor J. Piccini (Durham, US)

Does first line atrial fibrillation ablation improve survival in HFpEF?

Speaker: Professor G. Hindricks (Berlin, DE)

Does first line AF ablation improve outcome in asymptomatic patients?

Speaker: Professor K. Chun (Frankfurt, DE)

When to consider AF ablation: outcome and survival in specific cohorts – discussion.

Access the full session

When to consider AF ablation: outcome and survival in specific cohorts

Speakers: Doctor A. Creta, Professor J. Piccini, Professor G. Hindricks, Professor K. Chun

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources